A paper has recently been published demonstrating that AKV9 improves the health of mutant SOD1 mouse upper motor neurons in vitro much better than the FDA-approved ALS drugs riluzole and edaravone, and the combination of AKV9 with either of those drugs provides an additive effect.

Our Founder, Richard B. Silverman, was selected to receive the 2021 Tetrahedron Prize for Creativity in Organic Chemistry and will present a lecture at the Tetrahedron Symposium in Lisbon, Portugal this June.